COPENHAGEN, Denmark--(BUSINESS WIRE)--Santaris Pharma announced today the publication in Nature (Advance Online Publication (AOP) on www.nature.com/nature, March 26 2008) of a groundbreaking peer-reviewed study entitled LNA-mediated microRNA silencing in non-human primates. The paper is the first demonstration of microRNA silencing in non-human primates, providing an important validation of Santaris Pharma’s emerging clinical program to develop a novel class of LNA-based therapeutics capable of silencing disease-associated microRNAs.
